Case-Control Study of the Glycotestâ„¢ HCC Panel Vs AFP for the Detection of Early-stage Hepatocellular Carcinoma
Active, not recruiting
- Conditions
- Carcinoma, HepatocellularCirrhosis, Liver
- First Posted Date
- 2019-03-18
- Last Posted Date
- 2025-03-13
- Lead Sponsor
- Glycotest, Inc.
- Target Recruit Count
- 766
- Registration Number
- NCT03878550
- Locations
- 🇺🇸
Stanford University School of Medicine, Stanford, California, United States
🇺🇸NYU Langone Health, New York, New York, United States
🇮🇱Hebrew University- Hadassah Medical Center, Jerusalem, Israel
© Copyright 2025. All Rights Reserved by MedPath